Skyscape Web Viewer : The Maudsley Prescribing Guidelines in Psychiatry : Table Index

View All
Recommendations for treatment for depression in multiple sclerosis (MS)
Recommendations for treatment of psychosis in Parkinson's disease (PD)
Recommended actions in response to clozapine concentrations
Recommended drugs for rapid tranquillisation if the oral route is refused or has proven ineffective
Recommended first-line treatments for acute mania
Recommended minimum effective doses of antidepressants
Recommended psychotropics in renal impairment
Reduction or discontinuation regimen for antipsychotic drugs in BPSD - a guide57,58
Relative frequency sexual dysfunction (SD) with antidepressants
Reported associations between antidepressants and increased prolactin
Risk/extent of antipsychotic-induced weight gain (drugs in αbetical order)
Risk of perioperative blood loss and blood transfusion in SSRI users compared with non-SSRI users
Second-generation antipsychotics - approximate equivalent doses
Selected clinical features and risks in people with 22q11.2 deletion syndrome.
Severe alcohol withdrawal
Short Alcohol Withdrawal Scale (SAWS)
Some notes on currently and historically used medications for behaviour disorder
Starting treatment with Aristada
Stimulants in depression
Suggested monitoring for myocarditis
Suggested options for augmenting clozapine
Summary of alternatives to clozapine in refractory schizophrenia
Summary of antipsychotic/oestrogen interactions
Summary of British Association for Psychopharmacology recommendations
Summary of haematological changes associated with psychotropics
Summary of pharmacotherapy for depression in children and adolescents
Summary of psychiatric adverse drug reactions (ADRs) with non-psychotropics
Summary of risk of hyponatraemia with antidepressants
Summary of treatments for mental state and behavioural changes in Huntington's disease
Switching from risperidone long-acting injections